Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$892M |
| 2 |
Merck
MRK
|
+$858M |
| 3 |
Amgen
AMGN
|
+$857M |
| 4 |
Home Depot
HD
|
+$837M |
| 5 |
Cisco
CSCO
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$776M |
| 2 |
United Parcel Service
UPS
|
+$615M |
| 3 |
Qualcomm
QCOM
|
+$587M |
| 4 |
Alibaba
BABA
|
+$555M |
| 5 |
Eaton
ETN
|
+$508M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 11.88% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Unity Bancorp
UNTY
$591M
| $404K | ﹤0.01% |
18,341
| – | – |
|
3152
ASML
ASML
$626B
| $402K | ﹤0.01% |
651
-165
| -20% | -$91.5K |
|
3153
Information Services Group
III
$199M
| $401K | ﹤0.01% |
90,990
| – | – |
|
3154
Richmond Mutual Bancorp
RMBI
$251M
| $400K | ﹤0.01% |
29,458
-3,100
| -10% | -$41.8K |
|
3155
Aclaris Therapeutics
ACRS
$726M
| $398K | ﹤0.01% |
15,789
-4,716
| -23% | -$92.2K |
|
|
MBII
3156
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $398K | ﹤0.01% |
190,160
+17,587
| +10% | +$36.5K |
|
3157
Gyre Therapeutics
GYRE
$641M
| $397K | ﹤0.01% |
10,499
+3,667
| +54% | +$168K |
|
3158
Solid Biosciences
SLDB
$794M
| $397K | ﹤0.01% |
4,779
+863
| +22% | +$95.5K |
|
|
CHMI
3159
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $395K | ﹤0.01% |
42,218
+3,262
| +8% | +$31.1K |
|
3160
First Capital
FCAP
$212M
| $395K | ﹤0.01% |
8,095
+285
| +4% | +$15.2K |
|
3161
Atlanticus Holdings
ATLC
$1.59B
| $394K | ﹤0.01% |
12,962
+2,113
| +19% | +$58.5K |
|
3162
Avalo Therapeutics
AVTX
$965M
| $394K | ﹤0.01% |
45
+6
| +15% | +$56.7K |
|
3163
Eagle Bancorp Montana
EBMT
$187M
| $394K | ﹤0.01% |
16,186
| – | – |
|
|
CKPT
3164
DELISTED
Checkpoint Therapeutics
CKPT
| $393K | ﹤0.01% |
12,490
-1,277
| -9% | -$42.8K |
|
3165
Hamilton Beach Brands
HBB
$311M
| $392K | ﹤0.01% |
21,579
-26,551
| -55% | -$482K |
|
3166
Mustang Bio
MBIO
$4.32M
| $391K | ﹤0.01% |
157
| – | – |
|
3167
Princeton Bancorp
BPRN
$281M
| $389K | ﹤0.01% |
13,589
| – | – |
|
3168
DHI Group
DHX
$182M
| $389K | ﹤0.01% |
116,062
+229
| +0.2% | +$652 |
|
3169
Riverview Bancorp
RVSB
$107M
| $387K | ﹤0.01% |
55,763
+6,037
| +12% | +$37.1K |
|
3170
Gaia
GAIA
$46.8M
| $379K | ﹤0.01% |
31,827
+3,096
| +11% | +$33.7K |
|
|
NETI
3171
DELISTED
Eneti Inc.
NETI
| $378K | ﹤0.01% |
17,974
-1,975
| -10% | -$39.7K |
|
3172
Fresenius Medical Care
FMS
$13.8B
| $377K | ﹤0.01% |
+10,220
| New | +$387K |
|
3173
Philips
PHG
$25.7B
| $377K | ﹤0.01% |
8,159
-812
| -9% | -$36.9K |
|
3174
Banco Santander
SAN
$201B
| $377K | ﹤0.01% |
+110,037
| New | +$373K |
|
|
CNCE
3175
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $377K | ﹤0.01% |
75,468
+3,500
| +5% | +$28.3K |
|
Similar funds
Charles Schwab's Q1 2021 Portfolio in Review
As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
- Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
- Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
- Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
- Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
- Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.